Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why BioCryst Pharmaceuticals Stock Is Sinking Today

TheMotleyFool

0 0

Why BioCryst Pharmaceuticals Stock Is Sinking TodayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) are sinking today, down by 17.1% as of 11:09 a.m. ET. The big decline came after the drugmaker announced its fourth-quarter and full-year 2022 results before the market opened.

BioCryst reported Q4 revenue of $79.5 million, up from $47.2 million in the prior-year period. This result topped the consensus revenue estimate of $75.6 million.

The company posted a net loss in the fourth quarter of $71.5 million, or $0.38 per share, based on generally accepted accounting principles (GAAP). It posted a net loss of $17.8 million, or $0.10 per share, in Q4 2021. BioCryst recorded a non-GAAP loss of $73.6 million, or $0.40 per share.

Source Fool.com

Like: 0

BCRX

Teilen